1. Home
  2. Pharma & Healthcare
  3. Global Oxaliplatin Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Oxaliplatin Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Publication Month: Sep 2021 | No. of Pages: 146 Published By: GRD Survey
Single User License: US $ 3980
Corporate User License: US $ 7960

Executive Summary

According to GRD Survey data, the global Oxaliplatin market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the Oxaliplatin market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Oxaliplatin in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Mannitol
Glucose Solution
Lactose Solution
Other

Market Snapshot, By Application
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Other

Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia

Main Market Players Analyzed in this report, including:
YRPG
Yakult honsha
Teva
Sun Pharmaceutical
Sanofi-Aventis
Qilu Pharmaceutical
Nanjing Pharmaceutical Factory
Mylan
Luoxin
Lunan Pharmaceutical
Jiangsu Hengrui Medicine
Jiangsu Aosaikang Pharmaceutical
Jari Pharmaceutical
Hospira
Hisun Pharmaceutical
Halfsky Pharmacy
Hainan Jinrui Pharmaceutical
Fresenius Kabi
Dr Reddy's laboratories
Chiatai Tianqing

The study objectives of this report are:
To study and analyze the global Oxaliplatin market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Oxaliplatin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Oxaliplatin manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oxaliplatin market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Oxaliplatin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Oxaliplatin are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Oxaliplatin Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Oxaliplatin Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Oxaliplatin

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Oxaliplatin Sales Channel and Distributors Analysis
3.3.1 Oxaliplatin Sales Channel
3.3.2 Oxaliplatin Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 Oxaliplatin Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Oxaliplatin Type Introduction
4.1.1 Mannitol
4.1.2 Glucose Solution
4.1.3 Lactose Solution
4.1.4 Other
4.2 Global Oxaliplatin Sales by Type 2016-2021
4.3 Global Oxaliplatin Revenue by Type 2016-2021
4.4 Global Oxaliplatin Price by Type 2016-2021

5 Market Segment: by Application
5.1 Oxaliplatin Type Introduction
5.1.1 Colorectal Cancer
5.1.2 Stomach Cancer
5.1.3 Ovarian Cancer
5.1.3 Other
5.2 Global Oxaliplatin Sales by Application 2016-2021
5.3 Global Oxaliplatin Revenue by Application 2016-2021
5.4 Global Oxaliplatin Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Oxaliplatin Market by Region
6.1.1 Global Oxaliplatin Sales by Regions
6.1.2 Global Oxaliplatin Revenue by Regions
6.2 North America Oxaliplatin Market 2016-2021
6.3 Europe Oxaliplatin Market 2016-2021
6.4 Asia Pacific Oxaliplatin Market 2016-2021
6.5 South America Oxaliplatin Market 2016-2021
6.6 Middle East and Africa Oxaliplatin Market 2016-2021

7 North America
7.1 North America Oxaliplatin Market by Country 2016-2021
7.1.1 North America Oxaliplatin Sales by Country
7.1.2 North America Oxaliplatin Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Oxaliplatin Market by Country 2016-2021
8.1.1 Europe Oxaliplatin Sales by Country
8.1.2 Europe Oxaliplatin Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Oxaliplatin Market by Country 2016-2021
9.1.1 Asia Pacific Oxaliplatin Sales by Country
9.1.2 Asia Pacific Oxaliplatin Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Oxaliplatin Market by Country 2016-2021
10.1.1 South America Oxaliplatin Sales by Country
10.1.2 South America Oxaliplatin Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Oxaliplatin Market by Country 2016-2021
11.1.1 Middle East and Africa Oxaliplatin Sales by Country
11.1.2 Middle East and Africa Oxaliplatin Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 YRPG
12.1.1 YRPG Company Information
12.1.2 YRPG Oxaliplatin Product Portfolio, Specification and Application
12.1.3 YRPG Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 YRPG Key Development
12.2 Yakult honsha
12.2.1 Yakult honsha Company Information
12.2.2 Yakult honsha Oxaliplatin Product Portfolio, Specification and Application
12.2.3 Yakult honsha Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Yakult honsha Key Development
12.3 Teva
12.3.1 Teva Company Information
12.3.2 Teva Oxaliplatin Product Portfolio, Specification and Application
12.3.3 Teva Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Teva Key Development
12.4 Sun Pharmaceutical
12.4.1 Sun Pharmaceutical Company Information
12.4.2 Sun Pharmaceutical Oxaliplatin Product Portfolio, Specification and Application
12.4.3 Sun Pharmaceutical Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Sun Pharmaceutical Key Development
12.5 Sanofi-Aventis
12.5.1 Sanofi-Aventis Company Information
12.5.2 Sanofi-Aventis Oxaliplatin Product Portfolio, Specification and Application
12.5.3 Sanofi-Aventis Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Sanofi-Aventis Key Development
12.6 Qilu Pharmaceutical
12.6.1 Qilu Pharmaceutical Company Information
12.6.2 Qilu Pharmaceutical Oxaliplatin Product Portfolio, Specification and Application
12.6.3 Qilu Pharmaceutical Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Qilu Pharmaceutical Key Development
12.7 Nanjing Pharmaceutical Factory
12.7.1 Nanjing Pharmaceutical Factory Company Information
12.7.2 Nanjing Pharmaceutical Factory Oxaliplatin Product Portfolio, Specification and Application
12.7.3 Nanjing Pharmaceutical Factory Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Qilu Pharmaceutical Key Development
12.9 Luoxin
12.9.1 Luoxin Company Information
12.9.2 Luoxin Oxaliplatin Product Portfolio, Specification and Application
12.9.3 Luoxin Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Luoxin Key Development
12.8 Mylan
12.8.1 Mylan Company Information
12.8.2 Mylan Oxaliplatin Product Portfolio, Specification and Application
12.8.3 Mylan Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Mylan Key Development
12.11 Jiangsu Hengrui Medicine
12.11.1 Jiangsu Hengrui Medicine Company Information
12.11.2 Jiangsu Hengrui Medicine Oxaliplatin Product Portfolio, Specification and Application
12.11.3 Jiangsu Hengrui Medicine Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 Jiangsu Hengrui Medicine Key Development
12.12 Jiangsu Aosaikang Pharmaceutical
12.12.1 Jiangsu Aosaikang Pharmaceutical Company Information
12.12.2 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product Portfolio, Specification and Application
12.12.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Jiangsu Aosaikang Pharmaceutical Key Development
12.13 Jari Pharmaceutical
12.13.1 Jari Pharmaceutical Company Information
12.13.2 Jari Pharmaceutical Oxaliplatin Product Portfolio, Specification and Application
12.13.3 Jari Pharmaceutical Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
12.13.4 Jari Pharmaceutical Key Development
12.14 Hospira
12.14.1 Hospira Company Information
12.14.2 Hospira Oxaliplatin Product Portfolio, Specification and Application
12.14.3 Hospira Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
12.14.4 Hospira Key Development
12.15 Hisun Pharmaceutical
12.15.1 Hisun Pharmaceutical Company Information
12.15.2 Hisun Pharmaceutical Oxaliplatin Product Portfolio, Specification and Application
12.15.3 Hisun Pharmaceutical Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
12.15.4 Hisun Pharmaceutical Key Development
12.17 Hainan Jinrui Pharmaceutical
12.18 Fresenius Kabi
12.19 Dr Reddy's laboratories
12.20 Chiatai Tianqing

13 Global Oxaliplatin Market Forecast by Region by Type and by Application
13.1 Global Oxaliplatin Sales, Revenue Forecast 2022-2027
13.2 Global Oxaliplatin Forecast by Regions
13.2.1 Global Oxaliplatin Sales Forecast by Region 2022-2027
13.2.2 Global Oxaliplatin Revenue Forecast by Region 2022-2027
13.3 Global Oxaliplatin Forecast by Type
13.3.1 Global Oxaliplatin Sales Forecast by Type 2022-2027
13.3.2 Global Oxaliplatin Revenue Forecast by Type 2022-2027
13.3.3 Global Oxaliplatin Price Forecast by Type 2022-2027
13.4 Global Oxaliplatin Forecast by Application
13.4.1 Global Oxaliplatin Sales Forecast by Application 2022-2027
13.4.2 Global Oxaliplatin Revenue Forecast by Application 2022-2027
13.4.3 Global Oxaliplatin Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer


List of Tables

Table 1: Global Oxaliplatin Production Specifications
Table 2: Drivers in Oxaliplatin Market
Table 3: Restraints Oxaliplatin Market
Table 4: Opportunity in Oxaliplatin Market
Table 5: Comparion of Alternative and Oxaliplatin
Table 6: Oxaliplatin Raw Materials Key Suppliers List
Table 7: Oxaliplatin Distributors List
Table 8: Oxaliplatin Major Buyers in Application One
Table 9: Oxaliplatin Major Buyers in Application Two
Table 10: Oxaliplatin Major Buyers in Application Three
Table 11: Global Oxaliplatin Sales (K Units) by Type 2016-2021
Table 12: Global Oxaliplatin Sales Market Share by Type 2016-2021
Table 13: Global Oxaliplatin Revenue (Million USD) by Type 2016-2021
Table 14: Global Oxaliplatin Revenue Market Share by Type 2016-2021
Table 15: Global Oxaliplatin Price by Type 2016-2021
Table 16: Global Oxaliplatin Sales (K Units) by Application 2016-2021
Table 17: Global Oxaliplatin Sales Market Share by Application 2016-2021
Table 18: Global Oxaliplatin Revenue (Million USD) by Application 2016-2021
Table 19: Global Oxaliplatin Revenue Market Share by Application 2016-2021
Table 20: Global Oxaliplatin Price by Application 2016-2021
Table 21: Global Oxaliplatin Sales (K Units) by Region 2016-2021
Table 22: Global Oxaliplatin Sales Market Share by Region 2016-2021
Table 23: Global Oxaliplatin Revenue (Million USD) by Region 2016-2021
Table 24: Global Oxaliplatin Revenue Market Share by Region 2016-2021
Table 25: North America Oxaliplatin Sales (K Units) by Country 2016-2021
Table 26: North America Oxaliplatin Sales Market Share by Country 2016-2021
Table 27: North America Oxaliplatin Revenue (Million USD) by Country 2016-2021
Table 28: North America Oxaliplatin Revenue Market Share by Country 2016-2021)
Table 29: Europe Oxaliplatin Sales (K Units) by Country 2016-2021
Table 30: Europe Oxaliplatin Sales Market Share by Country 2016-2021
Table 31: Europe Oxaliplatin Revenue (Million USD) by Country 2016-2021
Table 32: Europe Oxaliplatin Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Oxaliplatin Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Oxaliplatin Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Oxaliplatin Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Oxaliplatin Revenue Market Share by Country 2016-2021)
Table 37: South America Oxaliplatin Sales (K Units) by Country 2016-2021
Table 38: South America Oxaliplatin Sales Market Share by Country 2016-2021
Table 39: South America Oxaliplatin Revenue (Million USD) by Country 2016-2021
Table 40: South America Oxaliplatin Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Oxaliplatin Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Oxaliplatin Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Oxaliplatin Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Oxaliplatin Revenue Market Share by Country 2016-2021)
Table 45 YRPG Company Information
Table 46 YRPG Oxaliplatin Product Portfolio, Specification and Application
Table 47 YRPG Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Yakult honsha Company Information
Table 49 Yakult honsha Oxaliplatin Product Portfolio, Specification and Application
Table 50 Yakult honsha Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Teva Company Information
Table 52 Teva Oxaliplatin Product Portfolio, Specification and Application
Table 53 Teva Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Sun Pharmaceutical Company Information
Table 55 Sun Pharmaceutical Oxaliplatin Product Portfolio, Specification and Application
Table 56 Sun Pharmaceutical Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Sanofi-Aventis Company Information
Table 58 Sanofi-Aventis Oxaliplatin Product Portfolio, Specification and Application
Table 59 Sanofi-Aventis Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Qilu Pharmaceutical Company Information
Table 61 Qilu Pharmaceutical Oxaliplatin Product Portfolio, Specification and Application
Table 62 Qilu Pharmaceutical Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Nanjing Pharmaceutical Factory Company Information
Table 64 Nanjing Pharmaceutical Factory Oxaliplatin Product Portfolio, Specification and Application
Table 65 Nanjing Pharmaceutical Factory Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 Mylan Company Information
Table 67 Mylan Oxaliplatin Product Portfolio, Specification and Application
Table 68 Mylan Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 Luoxin Company Information
Table 70 Luoxin Oxaliplatin Product Portfolio, Specification and Application
Table 71 Luoxin Oxaliplatin Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Oxaliplatin Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Oxaliplatin Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Oxaliplatin Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Oxaliplatin Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Oxaliplatin Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Oxaliplatin Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Oxaliplatin Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Oxaliplatin Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Oxaliplatin Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Oxaliplatin Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Oxaliplatin Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Oxaliplatin Revenue Market Share Forecast by Application (2022-2027)

Tables and Figures

List of Figures

Figure 1: Oxaliplatin Picture
Figure 2: Global Oxaliplatin Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Oxaliplatin Supply Chain Analysis
Figure 5: Oxaliplatin Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Mannitol
Figure 7: Product Picture of Glucose Solution
Figure 8: Global Oxaliplatin Sales Market Share by Type, 2020
Figure 9: Global Oxaliplatin Revenue Market Share by Type, 2020
Figure 10: Oxaliplatin in Colorectal Cancer
Figure 11: Global Oxaliplatin Market: Colorectal Cancer 2016-2021
Figure 12: Oxaliplatin in Stomach Cancer
Figure 13: Global Oxaliplatin Market: Stomach Cancer 2016-2021
Figure 14: Global Oxaliplatin Sales Market Share by Application, 2020
Figure 15: Global Oxaliplatin Revenue Market Share by Application, 2020
Figure 16: Global Oxaliplatin Sales Market Share by Region 2016-2021
Figure 17: Global Oxaliplatin Revenue Market Share by Region 2016-2021
Figure 18: North America Oxaliplatin Sales (K Units) Status 2016-2021
Figure 19: North America Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 20: Europe Oxaliplatin Sales (K Units) Status 2016-2021
Figure 21: Europe Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Oxaliplatin Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 24: South America Oxaliplatin Sales (K Units) Status 2016-2021
Figure 25: South America Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Oxaliplatin Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 28: North America Oxaliplatin Sales Market Share by Country, 2020
Figure 29: North America Oxaliplatin Revenue Market Share by Country, 2020
Figure 30: United States Oxaliplatin Sales (K Units) Status 2016-2021
Figure 31: United States Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 32: Canada Oxaliplatin Sales (K Units) Status 2016-2021
Figure 33: Canada Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Oxaliplatin Sales (K Units) Status 2016-2021
Figure 35: Mexico Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 36: Europe Oxaliplatin Sales Market Share by Country, 2020
Figure 37: Europe Oxaliplatin Revenue Market Share by Country, 2020
Figure 38: Germany Oxaliplatin Sales (K Units) Status 2016-2021
Figure 39: Germany Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 40: France Oxaliplatin Sales (K Units) Status 2016-2021
Figure 41: France Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 42: UK Oxaliplatin Sales (K Units) Status 2016-2021
Figure 43: UK Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 44: Italy Oxaliplatin Sales (K Units) Status 2016-2021
Figure 45: Italy Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 46: Russia Oxaliplatin Sales (K Units) Status 2016-2021
Figure 46: Russia Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 47: Spain Oxaliplatin Sales (K Units) Status 2016-2021
Figure 48: Spain Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Oxaliplatin Sales Market Share by Country, 2020
Figure 50: Asia Pacific Oxaliplatin Revenue Market Share by Country, 2020
Figure 51: China Oxaliplatin Sales (K Units) Status 2016-2021
Figure 52: China Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 53: Japan Oxaliplatin Sales (K Units) Status 2016-2021
Figure 54: Japan Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 55: Korea Oxaliplatin Sales (K Units) Status 2016-2021
Figure 56: Korea Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Oxaliplatin Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 59: India Oxaliplatin Sales (K Units) Status 2016-2021
Figure 60: India Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 61: Australia Oxaliplatin Sales (K Units) Status 2016-2021
Figure 62: Australia Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 63: South America Oxaliplatin Sales Market Share by Country, 2020
Figure 64: South America Oxaliplatin Revenue Market Share by Country, 2020
Figure 65: Brazil Oxaliplatin Sales (K Units) Status 2016-2021
Figure 66: Brazil Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Oxaliplatin Sales (K Units) Status 2016-2021
Figure 68: Argentina Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Oxaliplatin Sales (K Units) Status 2016-2021
Figure 70: Colombia Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Oxaliplatin Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Oxaliplatin Revenue Market Share by Country, 2020
Figure 73: Turkey Oxaliplatin Sales (K Units) Status 2016-2021
Figure 74: Turkey Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Oxaliplatin Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Oxaliplatin Sales (K Units) Status 2016-2021
Figure 78: South Africa Oxaliplatin Revenue (Million USD) Status 2016-2021
Figure 79: YRPG Oxaliplatin Revenue Market Share Globally (2019-2021)
Figure 80: Yakult honsha Oxaliplatin Revenue Market Share Globally (2019-2021)
Figure 81: Teva Oxaliplatin Revenue Market Share Globally (2019-2021)
Figure 82: Sun Pharmaceutical Oxaliplatin Revenue Market Share Globally (2019-2021)
Figure 83: Sanofi-Aventis Oxaliplatin Revenue Market Share Globally (2019-2021)
Figure 84: Qilu Pharmaceutical Oxaliplatin Revenue Market Share Globally (2019-2021)
Figure 85: Nanjing Pharmaceutical Factory Oxaliplatin Revenue Market Share Globally (2019-2021)
Figure 86: Mylan Oxaliplatin Revenue Market Share Globally (2019-2021)
Figure 87: Luoxin Oxaliplatin Revenue Market Share Globally (2019-2021)
Figure 88: Lunan Pharmaceutical Oxaliplatin Revenue Market Share Globally (2019-2021)
Figure 89: Global Oxaliplatin Sales (K Units) Forecast (2022-2027)
Figure 90: Global Oxaliplatin Sales (K Units) Forecast (2022-2027)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets